Pituitary Adenoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2013-11-04
Clinical Trial Update: Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas [Phase 2]
The Phase 2 exploratory trial of farletuzumab for resectable, non-functioning pituitary adenomas has been withdrawn.